Skip to main content
Top

Drug Safety

Issue 8/2014

Content (10 Articles)

Open Access Current Opinion

Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest

Richard D. Boyce, Patrick B. Ryan, G. Niklas Norén, Martijn J. Schuemie, Christian Reich, Jon Duke, Nicholas P. Tatonetti, Gianluca Trifirò, Rave Harpaz, J. Marc Overhage, Abraham G. Hartzema, Mark Khayter, Erica A. Voss, Christophe G. Lambert, Vojtech Huser, Michel Dumontier

Open Access Review Article

A Comparison of Active Adverse Event Surveillance Systems Worldwide

Yu-Lin Huang, Jinhee Moon, Jodi B. Segal

Review Article

Benefit-Risk Assessment of Orlistat in the Treatment of Obesity

Priya Sumithran, Joseph Proietto

Original Research Article

Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports

Alwis Nazir, Takashi Ichinomiya, Nobuteru Miyamura, Yasuaki Sekiya, Yasutomi Kinosada

Open Access Original Research Article

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank

Ola Caster, Kristina Juhlin, Sarah Watson, G. Niklas Norén

Original Research Article

Undesirable Effects Related to Oral Antineoplastic Drugs: Comparison Between Patients’ Internet Narratives and a National Pharmacovigilance Database

Arnaud Pages, Emmanuelle Bondon-Guitton, Jean Louis Montastruc, Haleh Bagheri

Open Access Original Research Article

Indicators of Drug-Seeking Aberrant Behaviours: The Feasibility of Use in Observational Post-Marketing Cohort Studies for Risk Management

Deborah Layton, Vicki Osborne, Mohammad Al-Shukri, Saad A. W. Shakir

Letter to the Editor

Comment on: “Pharmacovigilance in the Middle East”

Yaser Mohammed Al-Worafi